Congratulations to Modular Medical, Inc. (NASDAQ: MODD), a pioneering force in the insulin delivery technology sector, in successfully closing an $8.2 million firm commitment registered underwritten public offering.
This latest achievement underscores the company’s position as the first FDA-cleared patch pump designed specifically to target all adult “almost-pumpers” with its user-friendly and affordable design.
The offering, which garnered strong support from existing institutional investors, consisted of 5,450,573 shares of common stock at $1.50 per share. Manchester Explorer, L.P., the largest shareholder of the Company managed by Modular Medical’s Chief Executive Officer Jeb Besser, led the investment round
